MedPath

Effect of Injectable Platelet Rich Fibrin on Healing and Patient Satisfaction Following Laser Gingival Depigmentation

Phase 4
Completed
Conditions
Gingival Pigmentation
Interventions
Biological: i-PRF
Procedure: Diode Laser
Registration Number
NCT05283668
Lead Sponsor
Ain Shams University
Brief Summary

The objectives of the present study are to:

1. Evaluate the effect of I-PRF injection following laser gingival depigmentation technique on the healing period as a primary objective.

2. Assess patient satisfaction following the procedure in terms of pain and esthetic outcome as a secondary objective.

Detailed Description

Dental esthetic needs are increasing in recent years with a greater demand on pleasant appearance; including a healthy set of dentitions but also esthetically improved gingival appearance, especially when it is located in the anterior labial region. Physiologic gingival hyperpigmentation affects numerous people of different ethnic backgrounds.

Gingival depigmentation is defined as a periodontal plastic surgical procedure that are aimed at removing the pigmented gingiva and methods aimed at masking the pigmented gingiva. Techniques of gingival depigmentation can be classified as; chemical methods mainly by ascorbic acids, surgical methods, electrosurgery, cryosurgery, radiosurgery, and lasers.

The study was conducted on eight patients seeking treatment for their gingival hyperpigmentation for esthetic reasons. A total number of 16 sites of facial gingival hyperpigmentation were treated, two in each patient in a split mouth technique.

* Group I (LASER with I-PRF): Included eight sites that were treated with laser technique for gingival depigmentation, followed by intramucosal field injection of I-PRF (as study group).

* Group II (LASER): Included eight sites that were treated with laser technique for gingival depigmentation (as a control group).

The clinical outcomes were assessed for each patient: at baseline (pre-operative), post-operative, one week, one month. Clinical assessment was done by measuring DOPI, clinical wound healing, VAS and patient satisfaction questionnaire.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
8
Inclusion Criteria
  • Male and female with age range from 16 to 45 years old.
  • Systemically free from any disease as evidenced by the health questionnaire guided by modified Cornell medical index (Pendleton et al., 2004).
  • Gingival hyperpigmentation on maxillary and mandibular labial keratinized gingiva score 3 (Dummett et al., 1964).
  • Patient with thick gingival phenotype (>1.5mm) (Claffey and Shanley, 1986).

Exclusion Criteria

  • Pregnant and lactating women.
  • Smokers.
  • Gingival pigmentation associated with occupational Hazards.
  • Patients with missing anterior teeth.
  • Patients with any metallic restoration related to anterior teeth or undergoing orthodontic treatment.
  • Vulnerable groups (prisoners, handicapped and orphans).
Read More
Exclusion Criteria

Not provided

Read More

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
(LASER WITH I-PRF)i-PRFEight sites that were treated with laser method for gingival depigmentation, followed by intra-mucosal field injection of I-PRF
(LASER WITH I-PRF)Diode LaserEight sites that were treated with laser method for gingival depigmentation, followed by intra-mucosal field injection of I-PRF
(LASER WITHOUT I-PRF)Diode LaserEight sites that were treated with laser technique for gingival depigmentation only
Primary Outcome Measures
NameTimeMethod
Dummet oral pigmentation index1 month

the degree of gingival pigmentation will be scored as: 0 = pink tissue \[no clinical pigmentation\]; 1 = mild light brown tissue \[mild clinical pigmentation\]; 2 = medium brown or mixed brown and pink tissue \[moderate clinical pigmentation\]; or 3 = deep brown/ blue-black tissue \[heavy clinical pigmentation\]

Clinical wound healing1 week

scored as follows:

1) Complete reepithelialization, 2) Incomplete reepithelialization, 3) ulcer and 4) tissue defect or necrosis

Secondary Outcome Measures
NameTimeMethod
Satisfaction questionnaire1month

score the degree of satisfaction about cosmetic outcomes of treatment

Visual analogue scale (VAS) score for pain assessment1month

Pain assessment will be performed using a 10-cm (100 mm) horizontal continuous scale marked "no pain" on the left and "maximum pain" on the right side of the scale. The scores were as follows: no pain (0), slight pain (0.1-3.0 mm), moderate pain (3.1-6.0 mm), and severe pain (6.1-10 mm)

Histological assessment1 week

The mean of epithelial thickness for each case was calculated

Trial Locations

Locations (1)

Faculty of Dentistry Ain Shams University

🇪🇬

Cairo, Egypt

© Copyright 2025. All Rights Reserved by MedPath